antipsychotic (UCB Pharma)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameantipsychotic (UCB Pharma)

Drug Alias Namediarylmethylene-piperidine derivative (UCB Pharma)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonists

TargetsSerotonin 2 (5-HT2) receptor

Therapy Area/IndicationsPsychotic Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUcb Pharma Sa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesUcb Pharma Sa

Active IndicationsN/A

Inactive IndicationsPsychotic Disorders

ATC CodeN/A